Increased tone of skeletal muscles due to organic neurological disorders (e.g., injury of the pyramidal tract, multiple sclerosis, myelopathy, encephalomyelitis, etc.), muscular hypertension, muscular spasm, muscular contracture, rigidity, spinal automatism and discopathy, obliterative vascular diseases (obliterative arteriosclerosis, diabetic angiopathy, obliterative thromboangiitis, Raynaud's disease, diffuse scleroderma), and disorders due to injured innervation of the vessels (acrocyanosis, intermittent angioneurotic dysbasia). In individual cases, post-thrombotic venous and lymphatic circulation disorders, crural ulcer.

Tolperisone Hydrochloride is a centrally acting muscle relaxant. It effectively reduces muscular hypertonicity, improves peripheral blood flow by vasodilation, and reduces pain. Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action.

The usual dose is one ampoule twice daily by intramuscularly. Injection should be given slowly. Accordingly to age and symptom, the dosage may be changed.

Hypersensitivity to any component of the product Myasthenia gravis Nursing mother

Sometimes, muscular weakness, headache, nausea, vomiting, and rarely hypersensitivity reactions may occur as side effects.

Tolperisone hydrochloride should be used in pregnancy according to physician's advice. Tolperisone hydrochloride should not be used during breastfeeding.

In the case of children, the prescribed dose and duration of treatment should be closely observed.

In the event of overdosage, supportive therapy may be substituted.

Centrally acting Skeletal Muscle Relaxants, Locally acting Skeletal Muscle Relaxants

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.